Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

ALZN

Alzamend Neuro, Inc.

CIK 0001677077 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$1.56
↓ 0.07 (-4.29%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$7.47M
P/E Ratio
-0.85
EPS
-2.63
Dividend Yield
Not covered
52W Position
39%
Beta
1.83

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
10.19
P/S
Not covered
EV/Revenue
Not covered
ROE
-1196.4%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 39%
$0.84$2.68

Latest Financials

2026-04-30 FY
Revenue
–
Net Income
-$8.77M
Total Assets
$2.08M
Free Cash Flow
–

Recent news